Vincent Pai, Director, Product Management, Bruker Cellular Analysis
Vincent Pai is Director of Product Management at Bruker Cellular Analysis. He has over 10 years of experience in cell biology, nanotechnology, and microfluidics, with a background from UC San Diego and Massachusetts General Hospital in Boston. He now leads new product development for antibody discovery applications on the Beacon® optofluidic system.
Yu Liang, PhD, VP of Ab Drug Discovery, GenScript ProBio
Dr. Yu Liang received his Ph.D. degree in Virology/Microbiology from the University of Chicago and completed his postdoctoral training at NIAID, NIH. He then joined Novartis Inst. for Biomedical Research as a PI/lab head, and WuXi Biologics Discovery as Portfolio Director and Senior Project Leader. Currently he serves as VP of Ab Drug Discovery at GenScript ProBio, a global CDMO company providing end-to-end service from discovery to commercialization in cell and gene therapy (CGT), vaccine and antibody protein drug, to accelerate drug development for global customers. Dr. Liang has over 20 years of research experience in biomedical science in both academia and industry. His broad and in-depth knowledge & experience covers cellular / molecular biology, infectious diseases and molecular virology, viral/ tumor immunology and immunotherapy, and early phase drug discovery of bio-therapeutics, with special expertise in the discovery of therapeutic modalities based on therapeutic Abs (mAbs, BsAbs, ADCs, etc.).
